Arbutus Biopharma Corp
corporate_fare Company Profile
Arbutus Biopharma Corp (NASDAQ:ABUS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for ABUS at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Arbutus Biopharma Secures $950M Moderna Settlement, Reports Strong Q4/FY25 Results, and Advances HBV Program
- Arbutus Secures Up to $2.25 Billion from Moderna Patent Settlement, Plans Shareholder Capital Return
- Moderna to Pay Arbutus $950M in LNP Patent Settlement, Potential $1.3B More
- Court Bars Moderna's Obviousness & Derivation Defenses in Patent Suit, Enablement to Trial
- Court Bars Arbutus Biopharma's Doctrine of Equivalents Claims in Moderna Patent Suit
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$14.08M
Net Income
-$33.5M
Diluted EPS
-$0.17
Op. Cash Flow
-$39.64M
Free Cash Flow
-$39.64M
Operating Income
-$38.16M
Cash & Equivalents
$18.01M
Debt / Equity
0.00×
Net Margin
-237.9%
Shares Outstanding
192.53M sh
Source: 10-K · filed 2026-03-23 · accession 0001447028-26-000017
show_chartPrice Chart
Loading chart...
feed ABUS - Filings & News (Page 2)
ABUS
Mar 23, 2026, 7:31 AM EDT
Price at Filing:
$4.24
Real-time Price:
$3.98
Change:
-$0.260 (-6%)
Market Cap:
$616.237M
ABUS
Mar 23, 2026, 7:30 AM EDT
Arbutus Secures Up to $2.25 Billion from Moderna Patent Settlement, Plans Shareholder Capital Return
Price at Filing:
$4.24
Real-time Price:
$3.98
Change:
-$0.260 (-6%)
Market Cap:
$616.237M
ABUS
Mar 03, 2026, 4:23 PM EST
Price at Filing:
$5.10
Real-time Price:
$3.98
Change:
-$1.11 (-22%)
Market Cap:
$616.237M
ABUS
Feb 20, 2026, 4:01 PM EST
Price at Filing:
$4.27
Real-time Price:
$3.98
Change:
-$0.290 (-7%)
Market Cap:
$616.237M
ABUS
Feb 06, 2026, 4:01 PM EST
Price at Filing:
$3.87
Real-time Price:
$3.98
Change:
+$0.110 (+3%)
Market Cap:
$616.237M
ABUS
Jan 16, 2026, 7:41 AM EST
Price at Filing:
$4.06
Real-time Price:
$3.98
Change:
-$0.075 (-2%)
Market Cap:
$616.237M